Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2015-01-16)Premium Content



2015-03-30@12:07:50 ET
Orexigen Therapeutics Makes a Move: Up 2.0% (F77)

2015-03-30@08:45:00 ET
Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer (PRN)

2015-03-27@22:00:09 ET
OREXIGEN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Orexigen Therapeutics, Inc. -- OREX (PMZ)

2015-03-27@17:49:07 ET
Orexigen Therapeutics Rises 4.00% on Heavy Volume: Watch For Potential Pullback (PSM)

2015-03-27@17:00:05 ET
Barrack, Rodos & Bacine Has Filed an Investor Class Action Against Orexigen Therapeutics, Inc. (PMZ)

2015-03-27@14:05:01 ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Orexigen Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline -- OREX (PMZ)

2015-03-27@11:23:58 ET
Cohen Milstein Sellers & Toll PLLC Announces the Investigation of Orexigen Therapeutics, Inc. (PMZ)

2015-03-27@08:19:20 ET
Best Relative Performance in the Biotechnology Industry Detected in Shares of Orexigen Therapeutics (OREX, CYTK, OPK, NBIX, AMAG) (F70)

2015-03-27@04:48:15 ET
Orexigen's Mysimba granted marketing authorisation by European Commission (MTO)

2015-03-26@14:41:04 ET
Orexigen's Mysimba(TM) Approved in Europe for the Treatment of Obesity (EUR)

2015-03-26@14:22:00 ET
Orexigen's Mysimba(TM) Approved in Europe for the Treatment of Obesity (PRN)

2015-03-25@13:30:15 ET
Orexigen Therapeutics Shares Sinking Lower, Down 3.6% (F77)

2015-03-25@13:17:11 ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of OREXIGEN THERAPEUTICS, INC. of PENDENCY OF CLASS ACTION Lawsuit and a Lead Plaintiff DEADLINE of May 11, 2015 -- OREX (PMZ)

2015-03-25@11:54:00 ET
OREX Shareholder Alert: Investigation on Behalf of Orexigen Therapeutics, Inc. Investors Announced by Law Offices of Howard G. Smith (BIZ)

2015-03-24@09:35:05 ET
Deadline in Lawsuit for Investors in Orexigen Therapeutics, Inc. (NASDAQ:OREX) Shares Announced by Shareholders Foundation (PMZ)

2015-03-23@11:30:00 ET
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Orexigen Therapeutics, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit (BIZ)

2015-03-23@09:31:00 ET
Critical Alerts For Organovo, Orexigen Therapeutics, Facebook Released By InvestorsObserver (PRN)